Identification of patients with abnormal fractional shortening

作者: Ursula-Henrike Wienhues-Thelen , Serge Masson , Roberto Latini , Dirk Block , Christian Zaugg

DOI:

关键词:

摘要: The present invention relates to a method for assessing whether subject shall be subjected an imaging based diagnostic assessment. is on the determination of amount(s) cardiac Troponin and/or Fibroblast Growth Factor 23 (FGF-23) in sample from subject, and comparison the, thus, determined with reference amount (reference amounts). also system performing assessment reagents kits used methods disclosed herein. Moreover, directed predicting risk mortality cardiovascular event. Also encompassed diagnosing early stage LVH having preserved left ventricular ejection.

参考文章(33)
Duncan John Campbell, Diagnostic and prognostic assay ,(2011)
Lovorka Grgurevic, Slobodan Vukicevic, Boris Macek, Blood biomarkers for bone fracture and cartilage injury ,(2008)
Hendrik Hüdig, Andrea Horsch, Ursula-Henrike Wienhues-Thelen, Dietmar Zdunek, Georg Hess, Sabine Vogel-Ziebolz, Christine Böhm, Dirk Block, Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure ,(2011)
Stephen P.A. Fodor, J. Leighton Read, Michael C. Pirrung, Lubert Stryer, Arrays of materials attached to a substrate ,(1995)
Howard Kirchick, Jeffrey R. Dahlen, Gunars E. Valkirs, Kenneth F. Buechler, Diagnostic markers of acute coronary syndromes and methods of use thereof ,(2002)
Ursula-Henrike Wienhues-Thelen, Peter Liu, Dirk Block, Georg Hess, Sara Arab, Hendrik Huedig, Use of mimecan in the assessment of heart failure ,(2010)
Roberto Latini, Serge Masson, Inder S. Anand, Emil Missov, Marjorie Carlson, Tarcisio Vago, Laura Angelici, Simona Barlera, Giovanni Parrinello, Aldo P. Maggioni, Gianni Tognoni, Jay N. Cohn, Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure Circulation. ,vol. 116, pp. 1242- 1249 ,(2007) , 10.1161/CIRCULATIONAHA.106.655076